• BTC $8,024.45 (-2.18%)
  • ETH $175.80 (-0.48%)
  • MARKET CAP $223B
  • ICOs 4,247

Humanscape

ENDED 278 views
8
Total Rate

Humanscape can provide practical help for patients to overcome their diseases through intellectual and emotional interaction with each other based on community activities. This process is expected to generate and collect a high volume of patient data, namely PGHD, on various disease groups. Furthermore, Humanscape facilitates active research into incurable diseases and the development of new drugs by linking patients to external industry sectors such as pharmaceutical firms and research institutes and helps patients to avoid complications and enjoy healthy lives through the continuous self-management of their lifestyle and symptoms. With these services, Humanscape is taking steps to liberate patients from incurable diseases, as its contribution to a world where everyone is healthy.
General
Website: Visit
White paper: Read
Bounty: Bounty
Pre-sale Time: 22 Jun, 2018 - 29 Jun, 2018
Whitelist/KYC: Whitelist & Kyc
Country: Hong Kong
Token Info
Ticker: HUM
Platform: Ethereum
Token type: ERC20
Financial
ICO Price: 1 HUM = 0.01 USD
Social Media
  • 1

    Q1 2016

    Company Incorporation - Seoul, Korea (team foundation : 2014)

  • 2

    Q2 2016

    Development and Launch of ‘Beautycare’, a mobile application for aftercare services

  • 3

    Q3 2016

    Angel Investment Promotion from ‘Mashup Angels’ (Taek-Kyung Lee, CEO and Founder of ‘Daum’)

  • 4

    Q4 2016

    Client Usage Agreement with ‘Dream Medical Group’ and ‘DA Plastic Surgery’

  • 5

    Q1 2017

    Development and Beta test of ‘Helen’, Mobile Medical Assistant

  • 6

    Q2 2017

    Official Launch of ‘Helen’

  • 7

    Q3 2017

    Follow-up Investment Promotion from ‘Magellan Technology Investment(VC)’

  • 8

    Q4 2017

    Acquisition of 10,000 PHR Data from ‘Beautycare’ and ‘Helen’ Concept Building of ‘Humanscape’, a Health Information Ecosystem

  • 9

    Q1 2018

    Whitepaper publication Company Incorporation - Hongkong

  • 10

    Q2 2018

    ‘Humanscape’ MVP Development Begins Pre-sale 1st, 2nd and 3rd round

  • 11

    Q3 2018

    Main sale Test group(patients/health professionals) building Indonesia incorporation / Organization PoC

  • 12

    Q4 2018

    Exchange listing MVP release Alpha test PoC with global pharmaceutical companies and Contract research institutes

  • 13

    Q1 2019

    Beta test closing Soft launch (South Korea, Indonesia) Business model validation

  • 14

    Q2 2019

    Main launch (South Korea, Indonesia)

Min-hoo Chang

CEO

Won-woo Je

CSO

Tae-woo Lee

CTO

Hee-jeong Shin

Business Development

Yong-hyun Kim

Business Development

Tae-eun Kim

Business Development

Byung-ha Kim

Software Engineer

Hyun-sub Choi

Software Engineer

Back-seoung Choi

Software Engineer

Jung-min Yeom

Software Engineer

Do-Young Jeong

Software Engineer

Ji-yoo Choi

Marketing

Jung-won Lim

Marketing

Jin Woong Cho

Operation Managing

In-nyoung Choi

UX/UI Design

Myeong-jin Lee

UX/UI Design

Put this code to your website

Width: 420px-Height: 210px
comments powered by Disqus
Hot and trending ICOs
This website is using cookies. More info.